Contrafect Corp. Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals (Dec. 9, 2014)
By a News Reporter-Staff News Editor at Pharma Business Week– According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Contrafect Corp. was posted on December 9, 2014. The SEC file number is 0001011034-14-000134.. A U.S. Securities and Exchange Commission filing is a formal…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News